Atlas FDA

PerClot® Polysaccharide Hemostatic System

FDA premarket approval P210036/S008 · decided 2026-08-07

Approval details

PMA number
P210036
Supplement
S008
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PerClot® Polysaccharide Hemostatic System
Generic name
Agent, absorbable hemostatic, non-collagen based
Applicant
Baxter Healthcare Corporation
Date received
2026-02-27
Decision date
2026-08-07
Days to decision
161 days
Decision code
APPR
Product code
LMG
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Round Lake, IL
Statement
sterilization process modifications (increase in the maximum dose specification and change in product configuration in the irradiation container) of the PerClot® Polysaccharide Hemostatic System

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs) (K251745)Baxter Healthcare Corporation2025-12-16
SIGMA Spectrum Infusion Pump with Master Drug Library (K251640)Baxter Healthcare Corporation2025-07-28
Spectrum IQ Infusion System with Dose IQ Safety Software (3570009) (K251636)Baxter Healthcare Corporation2025-07-28
Solution Administration Sets (K243529)Baxter Healthcare Corporation2025-03-14
Intravascular Extension Sets and Accessories (K242339)Baxter Healthcare Corporation2025-02-28
Novum IQ Syringe Pump (40800BAXUS) (K242390)Baxter Healthcare Corporation2024-09-05
Actifuse ABX; Actifuse MIS; Actifuse Shape; ALTAPORE; ALTAPORE SHAPE; ALTAPORE MIS (K241564)Baxter Healthcare Corporation2024-08-02
Novum IQ Large Volume Pump (K211122)Baxter Healthcare Corporation2024-03-29